Synthesis and evaluation of a series of benzothiophene acrylonitrile analogs as anticancer agents
作者:Narsimha Reddy Penthala、Vijayakumar N. Sonar、Jamie Horn、Markos Leggas、Jai Shankar K. B. Yadlapalli、Peter A. Crooks
DOI:10.1039/c3md00130j
日期:——
A new library of small molecules with structural features resembling combretastatin analogs was synthesized and evaluated for anticancer activity against a panel of 60 human cancer cell lines. Three novel acrylonitrile analogs (5, 6 and 13) caused a significant reduction in cell growth in almost all the cell lines examined, with GI50 values generally in the range 10–100 nM. Based on the structural characteristics of similar drugs, we hypothesized that the cytotoxic activity was likely due to interaction with tubulin. Furthermore, these compounds appeared to overcome cell-associated P-glycoprotein (P-gp)-mediated resistance, since they were equipotent in inhibiting OVCAR8 and NCI/ADR-RES cell growth. Given that antitubulin drugs are among the most effective agents for the treatment of advanced prostate cancer we sought to validate the results from the 60 cell panel by studying the representative analog 6 utilizing prostate cancer cell lines, as well as exploring the molecular mechanism of the cytotoxic action of this analog.
我们合成了一个新的小分子库,其结构特征类似于考布他丁类似物,并评估了其对 60 种人类癌细胞株的抗癌活性。三种新型丙烯腈类似物(5、6 和 13)可显著降低几乎所有受检细胞系的细胞生长速度,其 GI50 值一般在 10-100 nM 之间。根据类似药物的结构特征,我们推测细胞毒性活性可能是由于与微管蛋白的相互作用。此外,这些化合物似乎还能克服细胞相关的P-糖蛋白(P-gp)介导的抗药性,因为它们在抑制OVCAR8和NCI/ADR-RES细胞生长方面效果相当。鉴于抗鸟嘌呤药物是治疗晚期前列腺癌最有效的药物之一,我们试图通过利用前列腺癌细胞系研究具有代表性的类似物 6 来验证 60 个细胞面板的结果,并探索这种类似物细胞毒性作用的分子机制。